Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
Apply
BG-C137
A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step